
Investigating whether the efficacy of bDMARDs is different in people with seropositive and seronegative rheumatoid arthritis
July 30, 2024
| Rheumatoid Arthritis
| Kaoru Takase-Minegishi
Dr. Takase-Minegishi's research examines whether serological status affects treatment responses to biological disease-modifying anti-rheumatic drugs.
View all Case Studies